FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit desired safety and dosage goals.
Money Talks News on MSN
More men die from hip fractures than women, but screening remains rare
A 50-year-old man is more likely to die from complications of a bone fracture than prostate cancer. Yet only 2% of older men ...
inews.co.uk on MSN
I’m a urologist, eight changes I made in my 50s to cut my risk of cancer
Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果